Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research    » Alternative Medicine    » Beta Cells    » Cause    » Cells    » Children    » Complications    » Control    » Cure    » Diagnosis    » Drugs    » Elderly    » Genes    » Immune Cells    » Inhaled Insulin    » Insulin    » Islet Cells    » Neuropathy    » Obesity    » Oral Insulin    » Other Diseases    » Pets    » Pre-Diabetes    » Prevention    » Research    » Retinopathy    » Risk Factors    » Stem Cells    » Technology    » Testing    » Transplants    » Treatments    » Trials    » Type 1    » Type 2 Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Research » Islet Cells

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Transplanted Pancreas Tissue May Lead to Better Glucose Control Posted: Wednesday, August 29, 2012

Israeli researchers have developed tissue from the islets of Langerhans that may help insulin-producing cells survive longer, and generate more insulin and other necessary hormones.

Pig Transplant Boosts Diabetes Hopes Posted: Sunday, November 20, 2011

A pig's pancreatic islets were transplanted into a diabetic monkey which was then administered a newly developed immune-regulating antibody. As a result, the monkey's blood-sugar level was automatically controlled without any rejection, and has been healthy for the last six months.

ProtoKinetix Forms Joint Venture Partnership to Launch a Dermatitis Therapeutic Product for the Skin Care Industry Posted: Wednesday, April 27, 2011

Upon completion of this formulation, the Joint Venture will be able to offer a topical preparation to specifically address skin conditions caused by inflammation. Conditions such as dermatitis, psoriasis and eczema are often treated with applications of corticosteroids or immune modulators, both of which carry inherent, long term health risks. “This Joint Venture supports ProtoKinetix’ pursuit of AAGP™ products for markets looking for safe and effective solutions to diseases and conditions caused by chronic inflammation and immune response deficiencies”.

Scientists Reveal New Clues to Origin of Diabetes Posted: Wednesday, October 27, 2010

Scientists have identified events inside insulin-producing pancreatic cells that set the stage for a neonatal form of non-autoimmune Type 1 diabetes, and may play a role in Type 2 diabetes as well.

Possible Groundbreaking Treatment for Diabetes Posted: Monday, August 09, 2010

A London company may be on the verge of a groundbreaking treatment for diabetes. A mini pancreas pouch could begin human clinical trials within a year.

Potential for Diabetes Patients to Create Their Own Insulin Posted: Sunday, June 27, 2010

Researchers have used a unique collection of pancreas specimens taken from patients who died soon after diagnosis of Type 1 diabetes to show that they respond to the ongoing process of destruction by inducing their islet cells to proliferate.

Andrew P. Mandell - Mr. Diabetes® to Sit On ProtoKinetix Advisory Board Posted: Friday, January 15, 2010

Andrew P. Mandell - Mr. Diabetes®, Executive Director of Defeat Diabetes Foundation and diabetes advocate announced today that he will be sitting on the ProtoKinetix (PKTX) Advisory Board. ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycoproteins (AAGP™) for medicine and the biotechnology and cosmetic industries.

ProtoKinetix’ AAGP™ Shows Promise as a Tool in Diabetes Treatment / Cure Posted: Tuesday, January 12, 2010

Independent studies done by universities and corporations have illustrated a remarkable increase in the yield of viable stem cells after cryopreservation using AAGP™ in the freeze-thaw process. One future approach to increasing diabetics’ insulin production is related to an ability to convert their stem cells into islet cells for transplantation. The feasibility of this procedure is dependent upon the amount of functioning islet cells that can be derived from the patient’s stem cells. This is where AAGP™ can make a very beneficial contribution.

First Pancreas Removal and Islet Cell Transplantation Performed Posted: Sunday, December 20, 2009

A 21-year old airman severely wounded in Afghanistan is recovering at Walter Reed Army Medical Center, Bethesda, MD, after several surgeries and an unprecedented transplant.

Phase II Begins for a New Islet Regeneration Treatment Posted: Wednesday, September 16, 2009

Exsulin Corporation announces next phase II trial of novel islet regeneration treatment in Type 1 diabetes. Leading diabetes research centers collaborate on new trial designed to further evaluate regeneration treatment for people with Type 1 diabetes.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.